Sleep Disordered Breathing in Children

Indian Journal of Pediatrics

Volumn 82, Issue 10, 2015, Pages 945-955

  Grime, Christopher ^a,b   Tan, Hui leng ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Morbidities; Pathophysiology; Pediatric obstructive sleep apnea

Indexed keywords

4 AMINOBUTYRIC ACID; BUDESONIDE; FLUTICASONE; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; MONTELUKAST; PHENETHYLAMINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; STEROID; TAURINE; TUMOR NECROSIS FACTOR ALPHA;

ACADEMIC ACHIEVEMENT; ADENOTONSILLAR HYPERTROPHY; ADENOTONSILLECTOMY; AIRWAY PRESSURE; APNEA HYPOPNEA INDEX; ATTENTION DEFICIT DISORDER; BREATHING PATTERN; CENTRAL SLEEP APNEA SYNDROME; CHILD; CHILDHOOD OBESITY; CLINICAL EVALUATION; COGNITIVE DEVELOPMENT; COR PULMONALE; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; ENDOSCOPY; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL FACTOR; FUNCTIONAL RESIDUAL CAPACITY; GENETIC VARIABILITY; GENOMICS; GOLD STANDARD; HEREDITY; HUMAN; HYPERCAPNIA; HYPOVENTILATION; HYPOXEMIA; INFLAMMATION; INSULIN SENSITIVITY; INTELLIGENCE QUOTIENT; ISOTONIC EXERCISE; LUNG FUNCTION TEST; MALOCCLUSION; METABOLIC DISORDER; MORBIDITY; MULTICHANNEL RECORDER; MUSCLE TRAINING; NERVOUS SYSTEM DEVELOPMENT; NOCTURNAL ENURESIS; NUTRITIONAL COUNSELING; ORTHODONTICS; OXIDATIVE STRESS; OXIMETRY; OXYGEN BREATHING; OXYGEN DESATURATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PERSONALIZED MEDICINE; PHENOTYPIC VARIATION; PHYSICAL ACTIVITY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROTEOMICS; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDERED BREATHING; SNORING; SURGICAL RISK; SYMPATHETIC FUNCTION; SYMPTOM; THORAX PRESSURE; TREATMENT DURATION; UPPER RESPIRATORY TRACT OBSTRUCTION; WATCHFUL WAITING; COMPLICATION; SLEEP APNEA SYNDROMES;

CHILD; HUMANS; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES;

EID: 84941994833     PISSN: 00195456     EISSN: 09737693     Source Type: Journal    
DOI: 10.1007/s12098-015-1857-5     Document Type: Review

References (73)

1. International Classification of Sleep Disorders. Third Edition (ICSD-3). IL: American Academy of Sleep Medicine, Darien; 2014.
2. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130:e714–55.
3. Arens R, McDonough JM, Costarino AT, et al. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2001;164:698–703.
4. Kim J, Bhattacharjee R, Dayyat E, et al. Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res. 2009;66:423–8.
5. Marcus CL, McColley SA, Carroll JL, Loughlin GM, Smith PL, Schwartz AR. Upper airway collapsibility in children with obstructive sleep apnea syndrome. J Appl Physiol. 1994;77:918–24.
6. Alonso-Alvarez ML, Cordero-Guevara JA, Teran-Santos J, et al. Obstructive sleep apnea in obese community-dwelling children: the NANOS study. Sleep. 2014;37:943–9.
7. Tauman R, Gozal D. Obesity and obstructive sleep apnea in children. Paediatr Respir Rev. 2006;7:247–59.
8. Spruyt K, Sans Capdevila O, Serpero LD, Kheirandish-Gozal L, Gozal D. Dietary and physical activity patterns in children with obstructive sleep apnea. J Pediatr. 2010;156:724–30. 730.e1-730.e3.
9. Gozal D, Serpero LD, Sans Capdevila O, Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med. 2008;9:254–9.
10. Khalyfa A, Capdevila OS, Buazza MO, Serpero LD, Kheirandish-Gozal L, Gozal D. Genome-wide gene expression profiling in children with non-obese obstructive sleep apnea. Sleep Med. 2009;10:75–86.
11. Kim J, Bhattacharjee R, Khalyfa A, et al. DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med. 2012;185:330–8.
12. Tan HL, Gozal D, Wang Y, et al. Alterations in circulating T-cell lymphocyte populations in children with obstructive sleep apnea. Sleep. 2013;36:913–22.
13. Gileles-Hillel A, Alonso-Alvarez ML, Kheirandish-Gozal L, et al. Inflammatory markers and obstructive sleep apnea in obese children: the NANOS study. Mediators Inflamm. 2014;2014:605280.
14. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics. 1998;102:616–20.
15. Kaemingk KL, Pasvogel AE, Goodwin JL, et al. Learning in children and sleep disordered breathing: findings of the Tucson Children’s Assessment of Sleep Apnea (tuCASA) prospective cohort study. J Int Neuropsychol Soc. 2003;9:1016–26.
16. Kheirandish-Gozal L, Yoder K, Kulkarni R, Gozal D, Decety J. Preliminary functional MRI neural correlates of executive functioning and empathy in children with obstructive sleep apnea. Sleep. 2014;37:587–92.
17. Gozal D, Capdevila OS, Kheirandish-Gozal L, Crabtree VM. APOE epsilon 4 allele, cognitive dysfunction, and obstructive sleep apnea in children. Neurology. 2007;69:243–9.
18. Gozal D, Sans Capdevila O, McLaughlin Crabtree V, Serpero LD, Witcher LA, Kheirandish-Gozal L. Plasma IGF-1 levels and cognitive dysfunction in children with obstructive sleep apnea. Sleep Med. 2009;10:167–73.
19. Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish-Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med. 2007;176:188–93.
20. Amin RS, Carroll JL, Jeffries JL, et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2004;169:950–6.
21. Goldbart AD, Levitas A, Greenberg-Dotan S, et al. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea. Chest. 2010;138:528–35.
22. Gozal D, Kheirandish-Gozal L, Serpero LD, Sans Capdevila O, Dayyat E. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation. 2007;116:2307–14.
23. Loffredo L, Zicari AM, Occasi F, et al. Endothelial dysfunction and oxidative stress in children with sleep disordered breathing: role of NADPH oxidase. Atherosclerosis. 2015;240:222–7.
24. Redline S, Storfer-Isser A, Rosen CL, et al. Association between metabolic syndrome and sleep-disordered breathing in adolescents. Am J Respir Crit Care Med. 2007;176:401–8.
25. Kaditis AG, Alexopoulos EI, Damani E, et al. Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol. 2005;40:515–23.
26. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med. 2008;177:1142–9.
27. Kheirandish-Gozal L, Sans Capdevila O, Kheirandish E, Gozal D. Elevated serum aminotransferase levels in children at risk for obstructive sleep apnea. Chest. 2008;133:92–9.
28. Nobili R, Bettinelli ME, Costantini D, Padoan R, Giunta A, Cesana B. Communication of the diagnosis of cystic fibrosis: theoretical considerations and practical indications. Acta Univ Carol Med (Praha). 1990;36:231–2.
29. Sundaram SS, Sokol RJ, Capocelli KE, et al. Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease. J Pediatr. 2014;164:699–706.e1.
30. Gozal D, Serpero LD, Kheirandish-Gozal L, Capdevila OS, Khalyfa A, Tauman R. Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep. 2010;33:319–25.
31. Khalyfa A, Serpero LD, Kheirandish-Gozal L, Capdevila OS, Gozal D. TNF-alpha gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr. 2011;158:77–82.
32. Jeyakumar A, Rahman SI, Armbrecht ES, Mitchell R. The association between sleep-disordered breathing and enuresis in children. Laryngoscope. 2012;122:1873–7.
33. Sans Capdevila O, Crabtree VM, Kheirandish-Gozal L, Gozal D. Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study. Pediatrics. 2008;121:e1208–14.
34. Nixon GM, Brouillette RT. Diagnostic techniques for obstructive sleep apnoea: is polysomnography necessary? Paediatr Respir Rev. 2002;3:18–24.
35. Alonso Alvarez Mde L, Teran Santos J, Cordero Guevara J, et al. Reliability of home respiratory polygraphy for the diagnosis of sleep apnea-hypopnea syndrome: analysis of costs. Arch Bronconeumol. 2008;44:22–8.
36. Alonso-Alvarez ML, Teran-Santos J, Ordax Carbajo E, et al. Reliability of home respiratory polygraphy for the diagnosis of sleep apnea in children. Chest. 2015;147:1020–8.
37. Tan HL, Gozal D, Ramirez HM, Bandla HP, Kheirandish-Gozal L. Overnight polysomnography versus respiratory polygraphy in the diagnosis of pediatric obstructive sleep apnea. Sleep. 2014;37:255–60.
38. Kaditis A, Kheirandish-Gozal L, Gozal D. Algorithm for the diagnosis and treatment of pediatric OSA: a proposal of two pediatric sleep centers. Sleep Med. 2012;13:217–27.
39. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130:576–84.
40. Wood JM, Cho M, Carney AS. Role of subtotal tonsillectomy (‘tonsillotomy’) in children with sleep disordered breathing. J Laryngol Otol. 2014;128:S3–7.
41. Zagolski O. Why do palatine tonsils grow back after partial tonsillectomy in children? Eur Arch Otorhinolaryngol. 2010;267:1613–7.
42. Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med. 2010;182:676–83.
43. Kirk VG, O’Donnell AR. Continuous positive airway pressure for children: a discussion on how to maximize compliance. Sleep Med Rev. 2006;10:119–27.
44. Fauroux B, Lavis JF, Nicot F, et al. Facial side effects during noninvasive positive pressure ventilation in children. Intensive Care Med. 2005;31:965–9.
45. McGinley B, Halbower A, Schwartz AR, Smith PL, Patil SP, Schneider H. Effect of a high-flow open nasal cannula system on obstructive sleep apnea in children. Pediatrics. 2009;124:179–88.
46. Tsaoussoglou M, Lianou L, Maragozidis P, et al. Cysteinyl leukotriene receptors in tonsillar B- and T-lymphocytes from children with obstructive sleep apnea. Sleep Med. 2012;13:879–85.
47. Tsaoussoglou M, Hatzinikolaou S, Baltatzis GE, et al. Expression of leukotriene biosynthetic enzymes in tonsillar tissue of children with obstructive sleep apnea: a prospective nonrandomized study. JAMA Otolaryngol Head Neck Surg. 2014;140:944–50.
48. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172:364–70.
49. Goldbart AD, Greenberg-Dotan S, Tal A. Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012;130:e575–80.
50. Kheirandish-Gozal L, Serpero LD, Dayyat E, et al. Corticosteroids suppress in vitro tonsillar proliferation in children with obstructive sleep apnoea. Eur Respir J. 2009;33:1077–84.
51. Kheirandish-Gozal L, Gozal D. Intranasal budesonide treatment for children with mild obstructive sleep apnea syndrome. Pediatrics. 2008;122:e149–55.
52. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr. 2001;138:838–44.
53. Kheirandish-Gozal L, Bhattacharjee R, Bandla HP, Gozal D. Antiinflammatory therapy outcomes for mild OSA in children. Chest. 2014;146:88–95.
54. Guilleminault C, Huang YS, Monteyrol PJ, Sato R, Quo S, Lin CH. Critical role of myofascial reeducation in pediatric sleep-disordered breathing. Sleep Med. 2013;14:518–25.
55. Villa MP, Brasili L, Ferretti A, et al. Oropharyngeal exercises to reduce symptoms of OSA after AT. Sleep Breath. 2015;19:281–9.
56. Villa MP, Malagola C, Pagani J, et al. Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med. 2007;8:128–34.
57. Pirelli P, Saponara M, Guilleminault C. Rapid maxillary expansion in children with obstructive sleep apnea syndrome. Sleep. 2004;27:761–6.
58. Nazarali N, Altalibi M, Nazarali S, Major MP, Flores-Mir C, Major PW. Mandibular advancement appliances for the treatment of paediatric obstructive sleep apnea: a systematic review. Eur J Orthod. 2015.
59. Wootten CT, Chinnadurai S, Goudy SL. Beyond adenotonsillectomy: outcomes of sleep endoscopy-directed treatments in pediatric obstructive sleep apnea. Int J Pediatr Otorhinolaryngol. 2014;78:1158–62.
60. Galluzzi F, Pignataro L, Gaini RM, Garavello W. Drug induced sleep endoscopy in the decision-making process of children with obstructive sleep apnea. Sleep Med. 2015;16:331–5.
61. Marcus CL, Moore RH, Rosen CL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368:2366–76.
62. Garetz SL, Mitchell RB, Parker PD, et al. Quality of life and obstructive sleep apnea symptoms after pediatric adenotonsillectomy. Pediatrics. 2015;135:e477–86.
63. Quante M, Wang R, Weng J, et al. The effect of adenotonsillectomy for childhood sleep apnea on cardiometabolic measures. Sleep. 2014.
64. Chervin RD, Ellenberg SS, Hou X, et al. Prognosis for spontaneous resolution of obstructive sleep apnea in children. Chest. 2015. doi:10.1378/chest.14-2873.
65. Mitchell RB, Garetz S, Moore RH, et al. The use of clinical parameters to predict obstructive sleep apnea syndrome severity in children: the Childhood Adenotonsillectomy (CHAT) study randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2015;141:130–6.
66. Katz ES, Moore RH, Rosen CL, et al. Growth after adenotonsillectomy for obstructive sleep apnea: an RCT. Pediatrics. 2014;134:282–9.
67. Konstantinopoulou S, Gallagher P, Elden L, et al. Complications of adenotonsillectomy for obstructive sleep apnea in school-aged children. Int J Pediatr Otorhinolaryngol. 2015;79:240–5.
68. Rosen CL, Wang R, Taylor HG, et al. Utility of symptoms to predict treatment outcomes in obstructive sleep apnea syndrome. Pediatrics. 2015;135:e662–71.
69. Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013;188:996–1004.
70. Becker L, Kheirandish-Gozal L, Peris E, Schoenfelt KQ, Gozal D. Contextualised urinary biomarker analysis facilitates diagnosis of paediatric obstructive sleep apnoea. Sleep Med. 2014;15:541–9.
71. Kheirandish-Gozal L, McManus CJ, Kellermann GH, Samiei A, Gozal D. Urinary neurotransmitters are selectively altered in children with obstructive sleep apnea and predict cognitive morbidity. Chest. 2013;143:1576–83.
72. Khalyfa A, Gozal D. Exosomal miRNAs as potential biomarkers of cardiovascular risk in children. J Transl Med. 2014;12:162.
73. Kheirandish-Gozal L, Gileles-Hillel A, Alonso-Alvarez ML, et al. Effects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: a community-based study. Int J Obes (Lond). 2015;39:1094–100.